Source: BEFREE

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23135
Gene Symbol: KDM6B
KDM6B
CUI: C1328402
Disease: Metastatic glioma
Metastatic glioma 		0.010 AlteredExpression BEFREE Immunohistochemical staining of a tissue microarray of glioma samples confirmed that JMJD3 overexpression could stratify highly metastatic glioma. 31788067

2019
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
CUI: C1328402
Disease: Metastatic glioma
Metastatic glioma 		0.010 Biomarker BEFREE In conclusion, LINC00673 silencing inhibits glioma cell migration and invasion by suppressing the PI3K/AKT signaling pathway, and it is a potential therapeutic target for the treatment of metastatic glioma. 29621055

2018
Entrez Id: 100499467
Gene Symbol: LINC00673
LINC00673
CUI: C1328402
Disease: Metastatic glioma
Metastatic glioma 		0.010 Biomarker BEFREE In conclusion, LINC00673 silencing inhibits glioma cell migration and invasion by suppressing the PI3K/AKT signaling pathway, and it is a potential therapeutic target for the treatment of metastatic glioma. 29621055

2018
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
CUI: C1328402
Disease: Metastatic glioma
Metastatic glioma 		0.010 Biomarker BEFREE In conclusion, LINC00673 silencing inhibits glioma cell migration and invasion by suppressing the PI3K/AKT signaling pathway, and it is a potential therapeutic target for the treatment of metastatic glioma. 29621055

2018
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
CUI: C1328402
Disease: Metastatic glioma
Metastatic glioma 		0.010 Biomarker BEFREE In conclusion, LINC00673 silencing inhibits glioma cell migration and invasion by suppressing the PI3K/AKT signaling pathway, and it is a potential therapeutic target for the treatment of metastatic glioma. 29621055

2018
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
CUI: C1328402
Disease: Metastatic glioma
Metastatic glioma 		0.010 Biomarker BEFREE In conclusion, LINC00673 silencing inhibits glioma cell migration and invasion by suppressing the PI3K/AKT signaling pathway, and it is a potential therapeutic target for the treatment of metastatic glioma. 29621055

2018